Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Kaufman, Dan S  [Clear All Filters]
Journal Article
Ferrell PI, Xi J, Ma C, Adlakha M, Kaufman DS. The RUNX1 +24 Enhancer and P1 Promoter Identify a Unique Subpopulation of Hematopoietic Progenitor Cells Derived from Human Pluripotent Stem Cells. Stem Cells. 2014.
Zhu H, Blum R, Bjordahl R, Gaidarova S, Rogers P, Lee TTong, Abujarour R, Bonello GB, Wu J, Tsai P-F, et al. Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity. Blood. 2019.
Angelos MG, Kaufman DS. Pluripotent stem cell applications for regenerative medicine. Curr Opin Organ Transplant. 2015;20(6):663-670.
Zhu H, Blum RH, Bernareggi D, Ask EHeggernes, Wu ZM, Hoel HJulie, Meng Z, Wu C, Guan K-L, Malmberg K-J, et al. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity. Cell Stem Cell. 2020.
Xue D, Lu S, Zhang H, Zhang L, Dai Z, Kaufman DS, Zhang J. Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapy. Trends Biotechnol. 2023.
Kidwai F, Edwards J, Zou L, Kaufman DS. Fibrinogen Induces RUNX2 Activity and Osteogenic Development from Human Pluripotent Stem Cells. Stem Cells. 2016.
Song W, Kaufman DS, Shen W. Efficient generation of endothelial cells from human pluripotent stem cells and characterization of their functional properties. J Biomed Mater Res A. 2015.
Bernarreggi D, Pouyanfard S, Kaufman DS. Development of innate immune cells from human pluripotent stem cells. Exp Hematol. 2019.